{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:59:53Z","timestamp":1790225993784,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:00:00Z","timestamp":1565913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:00:00Z","timestamp":1565913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10067-019-04724-w","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T05:02:51Z","timestamp":1565931771000},"page":"243-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Effectiveness and safety of abatacept for the treatment of patients with primary Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1007","volume":"39","author":[{"given":"Adriana Cristiane","family":"Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Caldas","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9841-3641","authenticated-orcid":false,"given":"Tania","family":"Fidelix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilda","family":"Lekwitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Barbosa","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Felipe","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Venturini","family":"Augusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson Carvas","family":"Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia Fernandes Mo\u00e7a","family":"Trevisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,16]]},"reference":[{"key":"4724_CR1","first-page":"1","volume-title":"Sj\u00f6gren\u2019s syndrome: diagnosis and therapeutics","author":"A Yannis","year":"2012","unstructured":"Yannis A, Drosos AA (2012) Epidemiology. In: Ramos-Casals M, Stone JH, Moutsoupoulos HM (eds) Sj\u00f6gren\u2019s syndrome: diagnosis and therapeutics. Springer- Verlag, New York, pp 1\u20139"},{"key":"4724_CR2","doi-asserted-by":"crossref","unstructured":"St. Clair EW (2017) Sj\u00f6gren\u2019s syndrome. In: Firestein GS, Gabriel SE, McInnes IB, O\u2019 Dell JR (ed) Kelley & Firestein\u2019s textbook of rheumatology. Elsevier, pp 1221\u20131244","DOI":"10.1016\/B978-0-323-31696-5.00073-5"},{"key":"4724_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/jama.2010.1014","volume":"304","author":"M Ramos-Casals","year":"2010","unstructured":"Ramos-Casals M, Tzioufas AG, Stone JH, Siso A, Bosch X (2010) Treatment of primary Sjogren syndrome: a systematic review. JAMA 304:452\u2013460. \nhttps:\/\/doi.org\/10.1001\/jama.2010.1014","journal-title":"JAMA"},{"key":"4724_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pharmthera.2017.10.019","volume":"184","author":"S Retamozo","year":"2018","unstructured":"Retamozo S, Flores-Chavez A, Consuegra-Fern\u00e1ndez M, Lozano F, Ramos-Casals M, Brito-Zeron P (2018) Cytokines as therapeutic targets in primary Sj\u00f6gren syndrome. Pharmacol Ther 184:81\u201397. \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2017.10.019","journal-title":"Pharmacol Ther"},{"key":"4724_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2014.7682","volume":"312","author":"JE Gottenberg","year":"2014","unstructured":"Gottenberg JE, Ravaud P, Puechal X, Le Guern V, Sibilia J, Goeb V, Larroche C, Dubost JJ, Rist S, Saraux A, Devauchelle-Pensec V, Morel J, Hayem G, Hatron P, Perdriger A, Sene D, Zarnitsky C, Batouche D, Furlan V, Benessiano J, Perrodeau E, Seror R, Mariette X (2014) Effects of hydroxychloroquine on symptomatic improvement in primary Sjogren syndrome: the JOQUER randomized clinical trial. JAMA 312:249\u2013258. \nhttps:\/\/doi.org\/10.1001\/jama.2014.7682","journal-title":"JAMA"},{"key":"4724_CR6","first-page":"149","volume":"11","author":"PC Fox","year":"1993","unstructured":"Fox PC, Datiles M, Atkinson JC, Macynski AA, Scott J, Fletcher D, Valdez IH, Kurrasch RH, Delapenha R, Jackson W (1993) Prednisone and piroxicam for treatment of primary Sjogren's syndrome. Clin Exp Rheumatol 11:149\u2013156","journal-title":"Clin Exp Rheumatol"},{"key":"4724_CR7","first-page":"896","volume":"25","author":"EJ Price","year":"1998","unstructured":"Price EJ, Rigby SP, Clancy U, Venables PJ (1998) A double blind placebo controlled trial of azathioprine in the treatment of primary Sjogren's syndrome. J Rheumatol 25:896\u2013899","journal-title":"J Rheumatol"},{"key":"4724_CR8","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/ar2322","volume":"9","author":"P Willeke","year":"2007","unstructured":"Willeke P, Schluter B, Becker H, Schotte H, Domschke W, Gaubitz M (2007) Mycophenolate sodium treatment in patients with primary Sjogren syndrome: a pilot trial. Arthritis Res Ther 9:R115. \nhttps:\/\/doi.org\/10.1186\/ar2322","journal-title":"Arthritis Res Ther"},{"key":"4724_CR9","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1056\/NEJM199610313351807","volume":"335","author":"H Reiser","year":"1996","unstructured":"Reiser H, Stadecker MJ (1996) Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 335:1369\u20131377. \nhttps:\/\/doi.org\/10.1056\/NEJM199610313351807","journal-title":"N Engl J Med"},{"key":"4724_CR10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/annrheumdis-2013-204653","volume":"73","author":"PM Meiners","year":"2014","unstructured":"Meiners PM, Vissink A, Kroese FG, Spijkervet FK, Smitt-Kamminga NS, Abdulahad WH, Bulthuis-Kuiper J, Brouwer E, Arends S, Bootsma H (2014) Abatacept treatment reduces disease activity in early primary Sjogren's syndrome (open-label proof of concept ASAP study). Ann Rheum Dis 73:1393\u20131396. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2013-204653","journal-title":"Ann Rheum Dis"},{"key":"4724_CR11","doi-asserted-by":"publisher","first-page":"e000022","DOI":"10.1136\/rmdopen-2014-000022","volume":"1","author":"R Seror","year":"2015","unstructured":"Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dorner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, Gerli R, Bijlsma JW, Kruize AA, Bombardieri S, Bookman A, Kallenberg C, Meiners P, Brun JG, Jonsson R, Caporali R, Carsons S, De Vita S, Del Papa N, Devauchelle V, Saraux A, Fauchais AL, Sibilia J, Hachulla E, Illei G, Isenberg D, Jones A, Manoussakis M, Mandl T, Jacobsson L, Demoulins F, Montecucco C, Ng WF, Nishiyama S, Omdal R, Parke A, Praprotnik S, Tomsic M, Price E, Scofield H, K LS, Smolen J, Laque RS, Steinfeld S, Sutcliffe N, Sumida T, Valesini G, Valim V, Vivino FB, Vollenweider C (2015) EULAR Sjogren's syndrome disease activity index (ESSDAI): a user guide. RMD Open 1:e000022. \nhttps:\/\/doi.org\/10.1136\/rmdopen-2014-000022","journal-title":"RMD Open"},{"key":"4724_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjogren's S (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558. \nhttps:\/\/doi.org\/10.1136\/ard.61.6.554","journal-title":"Ann Rheum Dis"},{"key":"4724_CR13","first-page":"143","volume":"39","author":"RM Ciconelli","year":"1999","unstructured":"Ciconelli RM, Ferraz MB, Santos W, Mein\u00e3o I, Quaresma MR (1999) Validation of the Brazilian version of the generic six-dimensional short form quality of life questionnaire (SF-6D Brazil). Rev Bras Reumatol 39:143\u2013150","journal-title":"Rev Bras Reumatol"},{"key":"4724_CR14","first-page":"604","volume":"8","author":"K Webster","year":"1999","unstructured":"Webster K, Odom L, Peterman A, Lent L, Cella D (1999) The functional assessment of chronic illness therapy (FACIT) measurement system: validation of version 4 of the core questionnaire. Qual Life Res 8:604","journal-title":"Qual Life Res"},{"key":"4724_CR15","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/acr.22052","volume":"65","author":"S Adler","year":"2013","unstructured":"Adler S, Koerner M, Foerger F, Caversaccio MD, Villiger PM (2013) Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary Sj\u00f6gren's syndrome: a pilot study. Arthritis Care Res (Hoboken) 65:1862\u20131868","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4724_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3109\/14397595.2016.1158773","volume":"26","author":"H Tsuboi","year":"2016","unstructured":"Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Yagishita M, Takahashi H, Kurata I, Ohyama A, Honda F, Asashima H, Miki H, Umeda N, Kondo Y, Hirata S, Saito K, Tanaka Y, Horai Y, Nakamura H, Kawakami A, Sumida T (2016) Effectiveness of abatacept for patients with Sjogren's syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (rheumatoid arthritis with Orencia trial toward Sjogren's syndrome Endocrinopathy) trial. Mod Rheumatol 26:891\u2013899. \nhttps:\/\/doi.org\/10.3109\/14397595.2016.1158773","journal-title":"Mod Rheumatol"},{"key":"4724_CR17","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/art.40165","volume":"69","author":"GM Verstappen","year":"2017","unstructured":"Verstappen GM, Meiners PM, Corneth OBJ, Visser A, Arends S, Abdulahad WH, Hendriks RW, Vissink A, Kroese FGM, Bootsma H (2017) Attenuation of follicular helper T cell-dependent B cell hyperactivity by abatacept treatment in primary Sjogren's syndrome. Arthritis Rheumatol 69:1850\u20131861. \nhttps:\/\/doi.org\/10.1002\/art.40165","journal-title":"Arthritis Rheumatol"},{"key":"4724_CR18","unstructured":"Bristol-Myers Squibb 2019. A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of subcutaneous abatacept in adults with active primary Sj\u00f6gren\u2019s syndrome. \nhttps:\/\/ichgcp.net\/clinical-trials-registry\/NCT02915159\n\n. Accessed 07"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04724-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04724-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04724-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T19:06:29Z","timestamp":1597431989000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04724-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,16]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["4724"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04724-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,16]]},"assertion":[{"value":"9 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The study was approved by the local Ethics Committee. All procedures were in accordance with the ethical standards of the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients provided written informed consent for participation before undergoing any procedures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no financial relationships relevant to this article to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosure"}}]}}